Admission to AIM First day of trading Poolbeg Pharma (AIM: POLB), a clinical stage infectious disease pharmaceutical company with a capital light clinical model , is pleased to announce that admission of its entire issued share capital to trading on the AIM market of the London Stock Exchange will become effective and dealings will commence at 8.00 a.m. today under the ticker POLB and with the ISIN GB00BKPG7Z60 ( Admission ). The full Admission Document is available to view on the Company s website at www.poolbegpharma.com · Shares priced at 10p per share equating to a market capitalisation at Admission of £50m
Investegate |Poolbeg Pharma plc Announcements | Poolbeg Pharma plc: Intention to Float on AIM investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Headquartered in Dublin, Ireland, Uniphar is an international diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions - Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,600, the Group is active in Ireland, the UK, the Benelux, the Nordics and the US. The Company s vision is to improve patient access to pharmaco-medical products and treatments by enhancing connectivity between manufacturers and healthcare stakeholders. Uniphar represents a strong combination of scale, growth and profitability. Commercial & Clinical In Commercial & Clinical the Group provides sales, marketing & distribution solutions to multinational pharmaceutical and medical device manufacturers on an outsourced basis. Active in Ireland, the UK, Benelux, the Nordics and the US, the Group
Dublin, London | 8 April 2021: Uniphar plc (the Company or Uniphar ) wishes to announce that it is today posting to shareholders its Notice of Annual General Meeting ( AGM ) for 2021 together with its annual report and accounts for the year ended 31 December 2020 ( Annual Report ). The AGM will be held at 11.00 a.m. on 12 May 2021 at Uniphar s registered office, 4045 Kingswood Road, Citywest Business Park, Dublin 24, D24 V06K. Uniphar considers the well-being of shareholders, employees and attendees a top priority. Based on the latest available guidance from the Health Service Executive ( HSE ) in Ireland, the board of directors of Uniphar (the Board ) expect the AGM to proceed on 12 May 2021 but under very constrained circumstances. Given the severity of the circumstances and the health risks involved, Uniphar s directors will take all appropriate safety measures to ensure the safety of attendees and others involved in the AG